VOYA Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $90.7M | Sell |
|
|||||
2025
Q1 | $120M | Buy |
|
|||||
2024
Q4 | $110M | Sell |
|
|||||
2024
Q3 | $197M | Buy |
|
|||||
2024
Q2 | $75.9M | Sell |
|
|||||
2024
Q1 | $79.7M | Buy |
|
|||||
2023
Q4 | $66.8M | Sell |
|
|||||
2023
Q3 | $63.6M | Sell |
|
|||||
2023
Q2 | $57.6M | Sell |
|
|||||
2023
Q1 | $68.1M | Sell |
|
|||||
2022
Q4 | $68.4M | Buy |
|
|||||
2022
Q3 | $62.1M | Buy |
|
|||||
2022
Q2 | $30.3M | Buy |
|
|||||
2022
Q1 | $34.9M | Sell |
|
|||||
2021
Q4 | $32.2M | Buy |
|
|||||
2021
Q3 | $25.8M | Sell |
|
|||||
2021
Q2 | $24.4M | Sell |
|
|||||
2021
Q1 | $24.7M | Sell |
|
|||||
2020
Q4 | $27.2M | Buy |
|
|||||
2020
Q3 | $26.9M | Buy |
|
|||||
2020
Q2 | $28.4M | Buy |
|
|||||
2020
Q1 | $16.6M | Sell |
|
|||||
2019
Q4 | $12.9M | Buy |
|
|||||
2019
Q3 | $8.46M | Buy |
|
|||||
2019
Q2 | $9.44M | Buy |
|
|||||
2019
Q1 | $12.1M | Buy |
|
|||||
2018
Q4 | $10.8M | Buy |
|
|||||
2018
Q3 | $11.6M | Sell |
|
|||||
2018
Q2 | $10.1M | Buy |
|
|||||
2018
Q1 | $9.79M | Sell |
|
|||||
2017
Q4 | $10.8M | Sell |
|
|||||
2017
Q3 | $13.3M | Sell |
|
|||||
2017
Q2 | $14.8M | Buy |
|
|||||
2017
Q1 | $11.4M | Buy |
|
|||||
2016
Q4 | $10.7M | Buy |
|
|||||
2016
Q3 | $11.7K | Sell |
|
|||||
2016
Q2 | $10.4M | Sell |
|
|||||
2016
Q1 | $10.9M | Sell |
|
|||||
2015
Q4 | $16.6M | Sell |
|
|||||
2015
Q3 | $14.5M | Buy |
|
|||||
2015
Q2 | $15.3M | Buy |
|
|||||
2015
Q1 | $13.4M | Sell |
|
|||||
2014
Q4 | $12.3M | Sell |
|
|||||
2014
Q3 | $11.2M | Sell |
|
|||||
2014
Q2 | $9.71M | Buy |
|
|||||
2014
Q1 | $10.1M | Buy |
|
|||||
2013
Q4 | $9.15M | Sell |
|
|||||
2013
Q3 | $12M | Sell |
|
|||||
2013
Q2 | $26.8M | Buy |
|